ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Summit Therapeutics (SMMT) Technical (Analysis) Reports Summit Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Summit Therapeutics (SMMT)

Technical Analysis Report for NASDAQ stock SMMT Summit Therapeutics. Dated: 13 Jan 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock SMMT Summit Therapeutics then click here. or read Experts views on Summit Therapeutics or Forecast & share price targets of Summit Therapeutics

Summit Therapeutics Opened at 17.09 and Closed at: 16.81, which is -1.37% of previous session's close. It moved within a range of 16.27 and 17.50
The session was a Bearish session with an average volume of 3037393, which is -165.71% of previous session's volumes.

    A Golden cross was found 8 days back on short term averages

    A Golden cross was found 5 days back on mid term averages

    Support for tomorrow is 15.93 and resistance for tomorrow is 17.16
    These support and resistance points are valid for the first 5-15 minutes charts

    Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

    Support for tomorrow's hourly charts is 16.22, 15.63 resistance for tomorrow's hourly charts is 17.45, 18.09

    10 Day SMA for Summit Therapeutics (SMMT) is 18 and stock is trading below these levels. This is not a good sign for its short term trend

    20 Day SMA for Summit Therapeutics (SMMT) is 17.85 and the stock is trading below these levels. This is not a good sign for its mid term trend

    50 Day SMA for Summit Therapeutics (SMMT) is 17.86 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

    100 Day SMA is 19.51 and the stock is trading below these levels. This is not a good sign for its long term trend

    200 Day SMA Summit Therapeutics is 21.77 and stock is trading below these levels. This is not a good sign for its long term trend

    20 DMA of Summit Therapeutics is at 17.85 and 200 DMA is at 21.77, while 50 DMA and 100 DMA are at 17.86 and 19.51 respectively

    Summit Therapeutics (SMMT) moving average of 20 SMA is at 17.85 and 20 EMA is at 17.95

    Summit Therapeutics (SMMT) moving average of 50 SMA is at 17.86 and 50 EMA is at 18.33

    Summit Therapeutics (SMMT) moving average of 100 SMA is at 19.51 and 100 EMA is at 19.39

    Summit Therapeutics (SMMT) moving average of 200 SMA is at 21.77 and 200 EMA is at 20.04

    Amgen Inc has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Amgen Inc, about 2.97% more returns!

    Summit Therapeutics has performed better than Alphatec Holdings in short term. Holding Summit Therapeutics could be a better choice for now!

    Omeros Corporation has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Omeros Corporation, about 40.45% more returns!

    Phio Pharmaceuticals has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Phio Pharmaceuticals, about 11.54% more returns!

    Summit Therapeutics has performed better than Insulet Corporation in short term. Holding Summit Therapeutics could be a better choice for now!

    Crispr Therapeutics has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Crispr Therapeutics, about 3.16% more returns!

    Summit Therapeutics has performed better than Champions Oncology in short term. Holding Summit Therapeutics could be a better choice for now!

    Cytokinetics Incorporated has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Cytokinetics Incorporated, about 5.16% more returns!

    Quidel Corporation has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Quidel Corporation, about 17.87% more returns!

    Regenxbio Inc has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Regenxbio Inc, about 12.17% more returns!

    Sol Gel has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Sol Gel, about 50.44% more returns!

    Summit Therapeutics has performed better than Tiziana Life in short term. Holding Summit Therapeutics could be a better choice for now!

    Hologic Inc has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Hologic Inc, about 2.85% more returns!

    Healthways Inc has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Healthways Inc, about 5.99% more returns!

    Kala Pharmaceuticals has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Kala Pharmaceuticals, about 4.92% more returns!

    Summit Therapeutics Technical analysis of indicators

    Price action analysis of Summit Therapeutics (SMMT) based on a short term time period is neutral. A longer time frame might give a better analysis.

    ADX buy sell signal for Summit Therapeutics stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.

    MACD generated a SELL signal for Summit Therapeutics in short term and the sell signal is strong.

    Summit Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.

    Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down

    CCI has generated a SELL signal for Summit Therapeutics in short term and SELL signal is strong!

    RSI is generating a BUY signal in short term and the buying is gaining momentum.

    MRSI is in positive zone. This is a BUY zone

    Stock of Summit Therapeutics is picking up buying momentum according to indicator.

    Volume based indicators are showing selling momentum.

    Volume Weighted Averaged Price (VWAP) for short term is 17.87 and Summit Therapeutics SMMT stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

    People seem to be coming out and selling the Summit Therapeutics SMMT stock. Volume based technical analysis of Summit Therapeutics SMMT stock is negative.

    Summit Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

    Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

    Tomorrow's Predictions

    You should also read Tomorrow's Movement Predictions for NASDAQ stock SMMT Summit Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

    And SMMT Experts View which covers a lot of information including buying and selling signals

    SMMT future forecast & share price targets

    You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Summit Therapeutics or View Candle Stick Charts here

    Chart Summit Therapeutics (SMMT)  Technical (Analysis) Reports Summit Therapeutics [

    Videos related to: Summit Therapeutics (SMMT) Technical (Analysis) Reports Summit Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

    Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

    Hindi Video Most Important Stock Market Video. No Success Without This Formula

    Summit Therapeutics (SMMT)  Technical (Analysis) Reports Summit Therapeutics [

     

    Back to top